Texas Permanent School Fund boosted its position in shares of Halyard Health, Inc. (NYSE:HYH) by 0.8% during the second quarter, Holdings Channel reports. The fund owned 34,074 shares of the medical instruments supplier’s stock after buying an additional 284 shares during the period. Texas Permanent School Fund’s holdings in Halyard Health were worth $1,338,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. CENTRAL TRUST Co raised its position in Halyard Health by 1.0% in the first quarter. CENTRAL TRUST Co now owns 2,643 shares of the medical instruments supplier’s stock worth $101,000 after buying an additional 25 shares during the last quarter. Meadow Creek Investment Management LLC raised its position in Halyard Health by 1.1% in the first quarter. Meadow Creek Investment Management LLC now owns 2,660 shares of the medical instruments supplier’s stock worth $101,000 after buying an additional 28 shares during the last quarter. Glen Harbor Capital Management LLC raised its position in Halyard Health by 1.1% in the first quarter. Glen Harbor Capital Management LLC now owns 3,230 shares of the medical instruments supplier’s stock worth $123,000 after buying an additional 34 shares during the last quarter. Patten Group Inc. raised its position in Halyard Health by 0.4% in the first quarter. Patten Group Inc. now owns 19,629 shares of the medical instruments supplier’s stock worth $769,000 after buying an additional 75 shares during the last quarter. Finally, Somerset Trust Co raised its position in Halyard Health by 0.7% in the second quarter. Somerset Trust Co now owns 12,618 shares of the medical instruments supplier’s stock worth $495,000 after buying an additional 90 shares during the last quarter. 90.32% of the stock is currently owned by institutional investors.

Shares of Halyard Health, Inc. (NYSE:HYH) opened at 42.85 on Thursday. Halyard Health, Inc. has a 12 month low of $31.59 and a 12 month high of $43.78. The company has a market cap of $2.00 billion, a price-to-earnings ratio of 41.20 and a beta of 1.78. The firm has a 50-day moving average of $40.39 and a 200 day moving average of $38.93.

Halyard Health (NYSE:HYH) last issued its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.14. Halyard Health had a net margin of 3.06% and a return on equity of 8.29%. The firm had revenue of $399.20 million for the quarter, compared to analysts’ expectations of $399.16 million. During the same quarter in the prior year, the business earned $0.45 EPS. The business’s quarterly revenue was down .2% on a year-over-year basis. On average, analysts expect that Halyard Health, Inc. will post $1.98 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Halyard Health, Inc. (HYH) Position Boosted by Texas Permanent School Fund” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another website, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/08/17/halyard-health-inc-hyh-position-boosted-by-texas-permanent-school-fund.html.

A number of research firms recently weighed in on HYH. Zacks Investment Research raised shares of Halyard Health from a “sell” rating to a “buy” rating and set a $44.00 price target on the stock in a research report on Wednesday, May 3rd. TheStreet lowered shares of Halyard Health from a “b-” rating to a “c” rating in a research report on Wednesday, May 3rd. Deutsche Bank AG raised their price target on shares of Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a research report on Thursday, August 3rd. BidaskClub raised shares of Halyard Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 28th. Finally, Stephens raised shares of Halyard Health from an “equal weight” rating to an “overweight” rating in a research report on Thursday, August 3rd. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $42.25.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Stock Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related stocks with our FREE daily email newsletter.